A detailed history of Vanguard Group Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,496,112 shares of MIRM stock, worth $109 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,496,112
Previous 2,446,733 2.02%
Holding current value
$109 Million
Previous $83.7 Million 16.37%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$33.68 - $44.74 $1.66 Million - $2.21 Million
49,379 Added 2.02%
2,496,112 $97.3 Million
Q2 2024

Aug 13, 2024

BUY
$23.57 - $34.85 $5.54 Million - $8.19 Million
235,048 Added 10.63%
2,446,733 $83.7 Million
Q1 2024

May 10, 2024

SELL
$24.92 - $30.02 $6.59 Million - $7.94 Million
-264,559 Reduced 10.68%
2,211,685 $55.6 Million
Q4 2023

Feb 14, 2024

BUY
$27.14 - $34.93 $21.2 Million - $27.3 Million
782,901 Added 46.23%
2,476,244 $73.1 Million
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $2.43 Million - $3.24 Million
98,685 Added 6.19%
1,693,343 $53.5 Million
Q2 2023

Aug 14, 2023

BUY
$23.51 - $30.09 $7.54 Million - $9.65 Million
320,831 Added 25.19%
1,594,658 $41.3 Million
Q1 2023

May 15, 2023

BUY
$19.19 - $24.1 $221,241 - $277,848
11,529 Added 0.91%
1,273,827 $30.6 Million
Q4 2022

Feb 10, 2023

BUY
$17.59 - $23.83 $305,591 - $413,998
17,373 Added 1.4%
1,262,298 $24.6 Million
Q3 2022

Nov 14, 2022

BUY
$19.98 - $29.44 $5.23 Million - $7.71 Million
261,950 Added 26.65%
1,244,925 $26.2 Million
Q2 2022

Aug 12, 2022

BUY
$18.42 - $27.5 $4.01 Million - $5.99 Million
217,791 Added 28.46%
982,975 $19.1 Million
Q1 2022

May 13, 2022

SELL
$15.5 - $23.93 $669,057 - $1.03 Million
-43,165 Reduced 5.34%
765,184 $16.9 Million
Q4 2021

Feb 14, 2022

BUY
$13.05 - $19.35 $961,811 - $1.43 Million
73,702 Added 10.03%
808,349 $12.9 Million
Q3 2021

Nov 12, 2021

BUY
$13.95 - $20.18 $43,942 - $63,567
3,150 Added 0.43%
734,647 $14.6 Million
Q2 2021

Aug 13, 2021

BUY
$15.84 - $20.6 $11.6 Million - $15.1 Million
731,497 New
731,497 $12.6 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.61B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.